Keisha Alexander1, Kelsey Hazegh2, Fang Fang3, Derek Sinchar4, Joseph E Kiss5,6, Grier P Page7, Angelo DʼAlessandro1,2,8, Tamir Kanias2,9. 1. Department of Biochemistry and Molecular Genetics, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA. 2. Vitalant Research Institute, Denver, Colorado, USA. 3. RTI International, Research Triangle Park, North Carolina, USA. 4. Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 5. Vitalant, Pittsburgh, Pennsylvania, USA. 6. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 7. RTI International, Atlanta, Georgia, USA. 8. Division of Hematology, Department of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA. 9. Department of Pathology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA.
Abstract
BACKGROUND: Red blood cells (RBCs) derived from patients who receive testosterone replacement therapy (TRT) may be considered eligible for component production and transfusion. The aim of this study was to identify testosterone-dependent changes in RBC metabolism and to evaluate its impact on susceptibility to hemolysis during cold storage. STUDY DESIGN AND METHODS: We characterized stored RBCs from two cohorts of TRT patients who were matched with control donors (no TRT) based upon sex, age, and ethnicity. We further evaluated the impact of testosterone deficiency (orchiectomy) on RBC metabolism in FVB/NJ mice. RBC metabolites were quantified by ultra-high-pressure liquid chromatography-mass spectrometry. RBC storage stability was determined in RBC units from TRT and controls by quantifying storage, osmotic, and oxidative hemolysis. RESULTS: Orchiectomy in mice was associated with significant (P < 0.05) changes in RBC metabolism as compared with intact males including increased levels of acyl-carnitines, long-chain fatty acids (eg, docosapentaenoic acids), arginine, and dopamine. Stored RBCs from TRT patients exhibited higher levels of pentose phosphate pathway metabolites, glutathione, and oxidized purines (eg, hypoxanthine), suggestive of increased activation of antioxidant pathways in this group. Further analyses indicated significant changes in free fatty acids and acyl-carnitines in response to testosterone therapies. With regard to hemolysis, TRT was associated with enhanced susceptibility to osmotic hemolysis. Correlation analyses identified acyl-carnitines as significant modifiers of RBC predisposition to osmotic and oxidative hemolysis. CONCLUSIONS: These observations provide new insights into testosterone-mediated changes in RBC metabolome and biology that may impact the storage capacity and posttransfusion efficacy of RBCs from TRT donors.
BACKGROUND: Red blood cells (RBCs) derived from patients who receive testosterone replacement therapy (TRT) may be considered eligible for component production and transfusion. The aim of this study was to identify testosterone-dependent changes in RBC metabolism and to evaluate its impact on susceptibility to hemolysis during cold storage. STUDY DESIGN AND METHODS: We characterized stored RBCs from two cohorts of TRT patients who were matched with control donors (no TRT) based upon sex, age, and ethnicity. We further evaluated the impact of testosterone deficiency (orchiectomy) on RBC metabolism in FVB/NJ mice. RBC metabolites were quantified by ultra-high-pressure liquid chromatography-mass spectrometry. RBC storage stability was determined in RBC units from TRT and controls by quantifying storage, osmotic, and oxidative hemolysis. RESULTS: Orchiectomy in mice was associated with significant (P < 0.05) changes in RBC metabolism as compared with intact males including increased levels of acyl-carnitines, long-chain fatty acids (eg, docosapentaenoic acids), arginine, and dopamine. Stored RBCs from TRT patients exhibited higher levels of pentose phosphate pathway metabolites, glutathione, and oxidized purines (eg, hypoxanthine), suggestive of increased activation of antioxidant pathways in this group. Further analyses indicated significant changes in free fatty acids and acyl-carnitines in response to testosterone therapies. With regard to hemolysis, TRT was associated with enhanced susceptibility to osmotic hemolysis. Correlation analyses identified acyl-carnitines as significant modifiers of RBC predisposition to osmotic and oxidative hemolysis. CONCLUSIONS: These observations provide new insights into testosterone-mediated changes in RBC metabolome and biology that may impact the storage capacity and posttransfusion efficacy of RBCs from TRT donors.
Authors: Angelo D'Alessandro; Rachel Culp-Hill; Julie A Reisz; Mikayla Anderson; Xiaoyun Fu; Travis Nemkov; Sarah Gehrke; Connie Zheng; Tamir Kanias; Yuelong Guo; Grier Page; Mark T Gladwin; Steve Kleinman; Marion Lanteri; Mars Stone; Michael Busch; James C Zimring Journal: Transfusion Date: 2018-10-24 Impact factor: 3.157
Authors: Marianne E Nellis; Kenneth E Remy; Jacques Lacroix; Jill M Cholette; Melania M Bembea; Robert T Russell; Marie E Steiner; Susan M Goobie; Adam M Vogel; Gemma Crighton; Stacey L Valentine; Meghan Delaney; Robert I Parker Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.971
Authors: Travis Nemkov; Davide Stefanoni; Aarash Bordbar; Aaron Issaian; Bernhard O Palsson; Larry J Dumont; Ariel Hay; Anren Song; Yang Xia; Jasmina S Redzic; Elan Z Eisenmesser; James C Zimring; Steve Kleinman; Kirk C Hansen; Michael P Busch; Angelo D'Alessandro Journal: JCI Insight Date: 2021-02-08
Authors: Fatih Celal Alcicek; Tasnim Mohaissen; Katarzyna Bulat; Jakub Dybas; Ewa Szczesny-Malysiak; Magdalena Kaczmarska; Magdalena Franczyk-Zarow; Renata Kostogrys; Katarzyna M Marzec Journal: Front Physiol Date: 2022-02-18 Impact factor: 4.566
Authors: Alkmini T Anastasiadi; Vasiliki-Zoi Arvaniti; Efthymios C Paronis; Nikolaos G Kostomitsopoulos; Konstantinos Stamoulis; Issidora S Papassideri; Angelo D'Alessandro; Anastasios G Kriebardis; Vassilis L Tzounakas; Marianna H Antonelou Journal: Biomedicines Date: 2022-02-23